CLINICAL_TRIALS
trial_result
· 2025-04-06
Clinical Trial Update: MCLA-117 in Acute Myelogenous Leukemia [Phase 1]
Summary
A Phase 1 trial of MCLA-117 for acute myeloid leukemia has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merus B.V. | Conditions: Acute Myelogenous Leukemia, Acute Myeloid Leukemia | Phase 1 | Status: TERMINATED